Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
10/31/2012 | CN102757564A Preparation method and application of tree-like polyester-polyglycidol block polymer |
10/31/2012 | CN102757538A Intelligent natural polymer-synthetic polymer copolymer microgel and preparation method thereof |
10/31/2012 | CN102757505A Physiologically active polypeptide conjugate having prolonged in vivo half-life |
10/31/2012 | CN102757500A Pegylation modifier of long-acting thymosin alpha1 |
10/31/2012 | CN102757401A Preparation method and application of 4-trifluoroacetyl-7-oxo-1, 4-oxgyen nitrogen and high hydrogen hybrid |
10/31/2012 | CN102755868A Microcapsules produced from blended sol-gel precursors and method for producing the same |
10/31/2012 | CN102755669A Preparation method and application of fibrin glue composite recombinant human bone morphogenetic protein-2 (rhBMP-2) microsphere |
10/31/2012 | CN102755650A Mesoporous calcium silicon gel and preparation method and application thereof |
10/31/2012 | CN102755645A Influenza vaccines with reduced amount of emulsion adjuvant |
10/31/2012 | CN102755641A Application of chymotrypsin preparation in treating oral ulcer |
10/31/2012 | CN102755629A Component for forming bacterium-resisting and efficacy-enhancing inclusion compound together with vancomycin and preparation method and application thereof |
10/31/2012 | CN102755531A Injection for treating abdominal external hernia |
10/31/2012 | CN102755470A Cataplasm for treating cancer pain and preparation method thereof |
10/31/2012 | CN102755411A Method for improving humidity resistance of extract powder of Qiluyishen tablets |
10/31/2012 | CN102755396A Preparation process and matrix for gel cream for treating coronary heart disease |
10/31/2012 | CN102755347A Glucose electrolyte effervescent tablets and preparation method thereof |
10/31/2012 | CN102755337A Compound florfenicol injection and preparation method thereof |
10/31/2012 | CN102755334A Medicine composition of cycloartenyl ferulate |
10/31/2012 | CN102755325A Cefoxitin sodium medicinal composition, powder injection and preparation method thereof |
10/31/2012 | CN102755323A Medicinal composition for treating periodontitis and method for preparing sustained-release microsphere by using same |
10/31/2012 | CN102755314A Pharmaceutical composition taking podophyllotoxin as main active component and preparation method of same |
10/31/2012 | CN102755305A Transdermal therapeutic system comprising an adhesive layer method for siliconizing the back layer of the system and use of said back layer |
10/31/2012 | CN102755302A Delayed release preparation containing safe and reliable plasticizer and preparation method thereof |
10/31/2012 | CN102755301A Glimepiride tablet and preparation method thereof |
10/31/2012 | CN102755300A Voriconazole composition and preparation method thereof |
10/31/2012 | CN102755298A Preparation method and application of resveratrol freeze-dried polymer micelle |
10/31/2012 | CN102755296A Sterile lyophilized preparation containing fosaprepitant, and preparation method thereof |
10/31/2012 | CN102755295A Medicine composition containing limaprost with improved stability and preparation method thereof |
10/31/2012 | CN102755293A Preparation method of toltrazuril solid dispersion |
10/31/2012 | CN102755292A Vesicle-type medication system containing metformin, and application thereof |
10/31/2012 | CN102755290A Medicine composition containing ibuprofen |
10/31/2012 | CN102755289A Argatroban injection for resisting thrombus and preparation method thereof |
10/31/2012 | CN102755288A Sophocarpidine injection and preparation method thereof |
10/31/2012 | CN102755286A Gentamycin sulfate injection containing buffer agent |
10/31/2012 | CN102755285A Hormone cream |
10/31/2012 | CN102755284A Fluvastatin sustained-release medicinal composition |
10/31/2012 | CN102755283A Water-in-oil medicament nanodispersion compound thermosensitive hydrogel and preparation method thereof |
10/31/2012 | CN102755282A Temperature sensitive injectable drug-loading controlled release system |
10/31/2012 | CN102754831A Formula of propolis, balsam pear and ginkgo leaf composite preparation with function of reducing blood sugar |
10/31/2012 | CN102329438B Magnetic chitosan/doped rare earth compound particles and preparation method thereof |
10/31/2012 | CN102294034B Biomineralization material, and preparation method and application thereof |
10/31/2012 | CN102204883B Promethazine hydrochloride microenema prescription and preparation method thereof |
10/31/2012 | CN102198123B Ibuprofen microenema preparation and preparation method thereof |
10/31/2012 | CN102151242B In-situ gel slow-release preparation for anti-tuberculosis drugs and preparation method thereof |
10/31/2012 | CN102133212B Asarone medical composition |
10/31/2012 | CN102091027B Method for preparing antitumor small interfering RNA carrying magnetic nano probe |
10/31/2012 | CN102018665B Strictosamide injection and preparation method thereof |
10/31/2012 | CN102000340B Targeted polymer medicament carrier and preparation method and application thereof |
10/31/2012 | CN101974229B Polylactic acid-polyethylene glycol/europium doped calcium phosphate nano composite material, modified substance thereof and preparation of both |
10/31/2012 | CN101972395B Calming and decompressing traditional Chinese medicine composition and preparation method thereof |
10/31/2012 | CN101965199B Selenium containing modifying agents and conjugates |
10/31/2012 | CN101961495B Plant soft capsule material and preparation method thereof |
10/31/2012 | CN101940793B Hydroxypropyl-beta-cyclodextrin clathrate compound of cantharidin and cantharis extractive and preparation method thereof |
10/31/2012 | CN101926784B Electric hydrogel sticking agent for instantaneous pulse electric field transdermal drug administration and preparation method thereof |
10/31/2012 | CN101879250B Arthralgia relief gel paste and preparation method |
10/31/2012 | CN101850122B Cholesterylchitosan nano carrier as well as medicament-carried nano particle and preparation method thereof |
10/31/2012 | CN101827578B Inverted vesicles |
10/31/2012 | CN101732446B Emulsified oil for treating tinea pedis and preparation method thereof |
10/31/2012 | CN101541347B Drug carriers, their synthesis, and methods of use thereof |
10/31/2012 | CN101411747B Salvia root polyphenol acid orally disintegrating tablets and preparation method thereof |
10/31/2012 | CN101318022B Metal-polysaccharide conjugates and synthesis method |
10/31/2012 | CN101278936B Clear eye lotion containing latanoprost as effective ingredient |
10/31/2012 | CN101257890B Argatroban formulation comprising an acid as solubilizer |
10/31/2012 | CN101242816B Hcv inhibitors |
10/31/2012 | CN101234193B Stable water solution containing recombination human serum albumin fusion interferon |
10/31/2012 | CN101137395B Pharmaceutical composition containing hardly water soluble medicament |
10/30/2012 | US8299230 Nucleic acid molecules encoding antibodies that bind cell-associated CA 125/O772P |
10/30/2012 | US8299173 Method involving 1-benzotriazolyl carbonate esters of polymers |
10/30/2012 | US8299129 Peptide lipid-containing carrier and method for introducing compound into cells using same |
10/30/2012 | US8299128 Compositions comprising polymeric micelles for drug delivery |
10/30/2012 | US8299116 CCI-779 concentrate formulations |
10/30/2012 | US8299030 Peptide-based compounds |
10/30/2012 | US8299029 Stabilised solid compositions of factor VII polypeptides |
10/30/2012 | US8298817 Vector |
10/30/2012 | US8298595 Contact lens, method for producing same, and pack for storage and maintenance of a contact lens |
10/30/2012 | US8298575 consist of water-insoluble hydrophobic synthetic materials which do not significantly affect the pharmaceutical quality of the contents themselves, but improve usability of filled capsules with regard to function, longevity, and/or the geographic location of their use |
10/30/2012 | US8298572 Adhesive pharmaceutical preparation containing bisoprolol |
10/30/2012 | US8298571 Product and method for reducing substance craving |
10/30/2012 | US8298530 Stable lyophilized pharmaceutical formulation of IgG antibodies |
10/30/2012 | US8298521 Treatment for eye disorder |
10/30/2012 | CA2669355C Guggulphospholipid methods and compositions |
10/30/2012 | CA2595038C Modified tie-2 receptor ligands |
10/30/2012 | CA2561660C Pharmaceutical compositions of pyrimidine-2,4,6-triones |
10/30/2012 | CA2528460C Magnetic nanoparticles |
10/30/2012 | CA2516449C Bioadhesive liquid composition which is substantially free of water |
10/30/2012 | CA2506244C Methods for inhibiting viral replication in vivo |
10/30/2012 | CA2477101C Use of folates for preventing and treating inflammation and diseases associated with inflammation |
10/30/2012 | CA2466437C Compositions comprising a photosensitizer and a skin-penetration enhancer and their use in photodynamic treatment |
10/30/2012 | CA2461873C Systems, methods and apparatuses for manufacturing dosage forms |
10/30/2012 | CA2411374C Dual specificity antibodies and methods of making and using |
10/30/2012 | CA2360106C Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies |
10/26/2012 | WO2012145739A1 Compositions and methods for stabilization of active agents |
10/26/2012 | WO2012145632A1 Cyclodextrin-based polymers for therapeutic delivery |
10/26/2012 | WO2012145491A2 Composition and method for enhancing an immune response |
10/26/2012 | WO2012145470A2 Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents |
10/26/2012 | WO2012145460A2 Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents |
10/26/2012 | WO2012144943A1 Liquid carrier for oral delivery of a pharmacologically active agent |
10/26/2012 | WO2012144906A1 New compounds for treating, delaying and/or preventing a human genetic disorder such as myotonic dystrophy type 1 (dm1) |
10/26/2012 | WO2012144789A2 Non-animal soft capsule shell composition having improved disintegration and shell hardness |
10/26/2012 | WO2012144678A1 Drug delivery composition containing biocompatible cross-linked hyaluronic acid product |